Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T15:40:58.055Z.
Calculation as of: 2026-10-06T15:40:58.055Z.
Quote observation: 2026-10-06T15:40:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 533c4696450707580a389d0c8167e09da333cd728c1767827588ef029f48caf5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$603.31M
EV/FCF Ratio
4.96x
TTM Avg
12.45x
3Y Avg
11.11x
5Y Avg
9.59x
Market Cap
$593.29M
EV/FCF Ratio
N/A
TTM Avg
53.49x
3Y Avg
23.98x
5Y Avg
29.09x
Market Cap
$610.27M
EV/FCF Ratio
1095.29x
TTM Avg
684.49x
3Y Avg
684.49x
5Y Avg
386.65x
Market Cap
$577.15M
EV/FCF Ratio
N/A
TTM Avg
19.46x
3Y Avg
19.46x
5Y Avg
19.46x
Market Cap
$567.12M
EV/FCF Ratio
N/A
TTM Avg
34.57x
3Y Avg
33.80x
5Y Avg
13.57x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | $596.86M | N/A | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $603.31M | 4.96x | 12.45x | 11.11x | 9.59x |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.29M | N/A | 53.49x | 23.98x | 29.09x |
| AngioDynamics, Inc. (ANGO)vs › | $610.27M | 1095.29x | 684.49x | 684.49x | 386.65x |
| OrthoPediatrics Corp. (KIDS)vs › | $588.96M | N/A | N/A | N/A | N/A |
| Prime Medicine, Inc. (PRME)vs › | $621.32M | N/A | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $577.15M | N/A | 19.46x | 19.46x | 19.46x |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | N/A | 34.57x | 33.80x | 13.57x |
| CorMedix Inc. (CRMD)vs › | $567.21M | 1.82x | 8.01x | 10.23x | 10.23x |
| Climb Bio, Inc. (CLYM)vs › | $641.60M | N/A | 370.81x | 370.81x | 370.81x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
